Ismael Vergara Correa

Dr. Ismael Vergara Correa is a Senior Lecturer (Adjunct) and Senior Computational Biologist at the University of Sydney's Faculty of Medicine and Health, affiliated with the Melanoma Institute Australia. With over 10 years of experience in cancer research, he specializes in computational biology, genomics, and machine learning applications in oncology. His multidisciplinary expertise spans computer science, biostatistics, and biotechnology. He has contributed to over 60 publications (>4800 citations, h-index 28) and holds 3 international patents related to prognostic methods.

Research focuses on melanoma genomics, particularly in identifying prognostic biomarkers and molecular signatures. Notable work includes the discovery of the MIADx ancillary test for melanoma diagnosis and analysis of immune microenvironment dynamics in immunotherapy responses. His studies explore tumor heterogeneity, aneuploidy mechanisms, and therapeutic targets in skin cancers.

Publications emphasize clinical translation of genomic insights, including immune checkpoint blockade efficacy, seasonal toxicity patterns in immunotherapy, and spatial T cell profiling in metastatic melanoma. His work bridges computational analysis with clinical outcomes, aiming to improve diagnostic accuracy and treatment personalization.

Scientific achievements include 3 international patents and recognition through high-impact journals in oncology and immunology. His collaborations span academic and industry partnerships, driving innovation in cancer research and precision medicine.